A truly enlightening conversation with David Nutt on the transformative potential of science and innovation in addressing some of the most pressing issues in mental health and drug policy. Drug Science Imperial College London Vignesh 🏴‍☠️ #depressioniscurable #alchoholdeath

Excellent first session by David Nutt at the Philosophy & Ethics of Pain retreat. Is drug legislation creating a drugs problem? Why isn’t medical cannabis more widely available? And why when so many banned drugs have such potential as medical treatments can’t we even talk about them?

You'll be interested to read a short article analysing the recent FDA Advisory Committee’s views against MDMA therapy. This article is a joint publication by Drug Science, PAREA and Mind Medicine Australia. Read more: buff.ly/45G853b #psychedelics #fda #mdma

drugscience.org.uk/size-matters-h… a blog from the The Loop experts on rising strength of MDMA pills - read and take care

Pills strong again take care out there 🫡 ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️

The gov wants people back into work-the single biggest cause of #disability in the UK is #depression for which #psilocybin is a safe and effective medicine, yet we keep it in schedule1 for no scientific reason. Home Office please review the evidence! David Nutt The Needs of A Nation

new BBC programme on mushrooms including me talking about magic ones bbc.co.uk/programmes/w3c… Drug Science PAREA

thank you - am glad you liked it best Wishes Dave

thanks for posting this Drug Science GABA Labs

Grateful to Gus, Morten, & team for this demonstration of the solid intuition of David Nutt that these treatments work differently. The results also support the findings of Richard E. Daws suggesting a carryover-like flattening of hierarchy post psilocybin-therapy for MDD.

Brilliant debunking the FDA #MDMA advisory farce instagram.com/reel/C-beqweSr…

Important chance for you to influence future research funding for #Addictions please respond and share widely @drug_science too

Could Psychedelic-Assisted Therapy Change Addiction Treatment? New @JSADjournal articles explore the emerging role of psychedelics in the treatment of substance use disorders David Nutt Drug Science Celia Morgan Dr Dominique Morisano amanda rose pratt, phd Magdalena Harris jsad.com/do/10.15288/js…

Delighted to announce that Drug Science is running its first short training course in #psychedelics and therapy this autumn. - read more here drugscience.org.uk/psychedelic-tr…

Are you joining for the Eur Behav Pharm Soc. workshop in Banff next month?🤔 We're covering all your favorites - psilocybin, ketamine, MDMA, cannabinoids, orexins, & more! #EBPS2024 There's still time - registration closes in 10 days (Sept 9) so sign up now: ebps2024.azuleon.org

MoreKare - The new NIHR/Awakn ketamine for alcohol dependence study is starting - you can register interest at sites.exeter.ac.uk/morekare/. . Awakn™ Life Sciences #ketamine #alcoholic

Just announced - the start of an exciting new MDMA research initiative between Drug Science and UCL drugscience.org.uk/uclmdma

.Drug Science and University College London (UCL) are joining forces to address concerns over the therapy component of MDMA-assisted psychotherapy in light of the recent FDA rejection. David Nutt Find out more. 👇 psychedelichealth.co.uk/2024/09/04/dru…

Why we need a revolution in clinical research academic.oup.com/brain/article/… couldn't agree more - current UK medical research in Universities is so wasteful due to administrative duplication needed contracts etc etc -

was a pleasure